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Purpose
Glycogen storage disease (GSD) type 1a is an autosomal
recessive inborn error of carbohydrate metabolism which
affects glycogenolysis and gluconeogenesis. Severe fasting
hypoglycemia and secondary biochemical abnormalities
such as hyperuricemia occur. Molecular analysis differenti-
ates GSD type 1 into different clinical phenotypes, of
which Type 1b but not Type 1a, is associated with inflam-
matory bowel disease (IBD). While gout has been described
in GSD, chronic arthritis and uveitis have not.
Methods
Case report
A 15-year-old girl with GSD type 1a, presented with a 2
month history of right midfoot swelling. There were no
systemic features and no history of previous infections.
GSD type 1a had been diagnosed in infancy and genetic
testing was positive for the 83R>C mutation. Her mother
had inactive Crohn’s disease that had never required
treatment. On musculoskeletal examination, she had a
right midfoot arthritis but no enthesitis and back and
sacroiliac joint examinations were normal. She had a
mild microcytic anemia (Hgb 102 g/l) and an elevated
erythrocyte sedimentation rate (ESR) of 30 mm (Winth-
robe). No platelet dysfunction was identified. Serum uric
acid was 559 (180-350 umol/L), which normalized within
several months of strict dietary control. Serum glucose
was normal and lactate was 6.2 (0-2.5 mmol/L). HLA-
B27, rheumatoid factor (RF) and angiotensin converting
enzyme were negative. The antinuclear antibody (ANA)
was 1:80; extractable nuclear antigens (ENA), quantitative
immunoglobulin and complement levels and urinalysis
were normal. Abdominal ultrasound identified hepatic
steatosis, as expected, without hepatomegaly or adenoma.
X-rays of the right foot showed soft tissue swelling over
the dorsum of the foot and the chest x-ray was normal.
Subsequently, she developed right ankle and subtalar
joint arthritis. The synovial fluid from the ankle was
negative for both crystals and microorganisms. The right
ankle, subtalar and midfoot joints were injected with
triamcinolone hexacetonide, resulting in a short-lived
response. Sulfasalazine was added since Methotrexate
was contraindicated due to potential hepatotoxicity, com-
pounded by the underlying disease. An MRI with gadoli-
nium of the right ankle and foot confirmed synovitis and
tenosynovitis with normal bone architecture and joint
spaces. The patient then developed arthritis of the right
wrist, left knee and left ankle. Nine months after the
initial presentation, she developed anterior uveitis whose
course was chronic and asymptomatic. Due to persisting
disease activity and limited options for treatment due to
the underlying disease, Adalimumab was initiated, which
resulted in progressive and marked improvement of both
the uveitis and the arthritis and was well-tolerated.
Conclusion
This is the first description of a GSD patient with a
chronic form of arthritis and uveitis. Synovial fluid analysis
eliminated gout as a cause of arthritis. While IBD-related
arthritis might have been postulated as the underlying
cause, GSD type 1a is not associated with IBD. Of interest,
treatment with Adalimumab in this patient resulted in sig-
nificant resolution of both arthritis and uveitis.
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